Ligand Pharmaceuticals Completes Merger with XOMA Royalty Corporation

On July 14, 2026, Ligand Pharmaceuticals Incorporated completed its previously announced merger with XOMA Royalty Corporation. As part of the merger agreement, XOMA Royalty's Series A and Series B Cumulative Perpetual Preferred Stock were redeemed.